Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Dec 23, 2024 | 10.14 | +1.00 |
Oak Valley Bancorp | OVLY | Dec 23, 2024 | 28.27 | +1.04 |
Oak Woods Acquisition | OAKU | Dec 23, 2024 | 11.35 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Dec 23, 2024 | 10.10 | 0.00 |
Oaktree Capital A Pref | OAK-A | Dec 23, 2024 | 22.15 | -0.67 |
Oaktree Capital Group B Pref | OAK-B | Dec 23, 2024 | 21.44 | -0.80 |
Oaktree Specialty | OCSL | Dec 23, 2024 | 14.99 | -1.25 |
Oatly ADR | OTLY | Dec 23, 2024 | 0.61 | +0.82 |
Oblong | OBLG | Dec 23, 2024 | 3.53 | +0.28 |
Occidental Petroleum | OXY | Dec 23, 2024 | 47.84 | +1.51 |
Ocean Biomedical | OCEA | Dec 23, 2024 | 0.64 | -3.61 |
Ocean Power Technologies | OPTT | Dec 23, 2024 | 0.33 | -0.45 |
Oceaneering International | OII | Dec 23, 2024 | 24.79 | +0.98 |
OceanFirst Financial | OCFC | Dec 23, 2024 | 17.85 | +0.34 |
OceanFirst Pref | OCFCP | Dec 23, 2024 | 25.21 | +0.24 |
OceanPal | OP | Dec 23, 2024 | 1.09 | 0.00 |
Ocugen | OCGN | Dec 23, 2024 | 0.74 | -4.42 |
Ocular Therapeutix | OCUL | Dec 23, 2024 | 8.56 | +0.71 |
Oculis | OCS | Dec 23, 2024 | 16.82 | -0.91 |
Oddity Tech | ODD | Dec 23, 2024 | 44.58 | +1.87 |
Odyssey Marine Exploration | OMEX | Dec 23, 2024 | 0.35 | -2.46 |
Offerpad Solutions A | OPAD | Dec 23, 2024 | 3.42 | -6.30 |
Office Properties | OPI | Dec 23, 2024 | 0.98 | -3.57 |
OFG Bancorp | OFG | Dec 23, 2024 | 42.56 | +1.79 |
OFS Capital | OFS | Dec 23, 2024 | 7.96 | -1.12 |
OFS Credit | OCCI | Dec 23, 2024 | 7.11 | +0.35 |
OFS Credit C Pref | OCCIO | Dec 23, 2024 | 24.55 | -0.28 |
OFS Credit Company Pref F | OCCIM | Dec 23, 2024 | 25.00 | 0.00 |
OFS Credit E Pref | OCCIN | Dec 23, 2024 | 23.67 | +0.38 |
OGE Energy | OGE | Dec 23, 2024 | 41.28 | +0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.